U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07594509) titled 'Perioperative Vericiguat in Patients Undergoing Cardiovascular Surgery' on May 11.
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of perioperative vericiguat in patients undergoing cardiovascular surgery. Patients at high risk of heart failure or with confirmed cardiac dysfunction will be randomly assigned to receive either vericiguat plus standard of care or standard of care alone. The primary objective is to determine whether perioperative administration of vericiguat can reduce (I) the Incidence of Early Postoperative Hemodynamic Deterioration or Clinically Significant Myocardial Injury; (II) Incid...